KPIs & Operating Metrics(New)
Assets By SegmentBreakdown Of AssetsCapital Expenditure By SegmentContractual ObligationsCost Of Goods SoldDeferred RevenueEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome Before Income Tax By RegionNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Margin By Segment %Operating Margin By Segment Annual %Operating Profit (Loss) By SegmentOperating Profit (Loss) By Segment AnnualOpex As A % Of Total Revenue %OPEX SegregationProperty And Equipment By GeographyProperty And Equipment, Net BreakdownRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Gross Profit (2016 - 2025)

Bio-Rad Laboratories has reported Gross Profit over the past 18 years, most recently at $309.4 million for Q1 2026.

  • Quarterly Gross Profit rose 1.11% to $309.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Mar 2026, down 1.16% year-over-year, with the annual reading at $1.3 billion for FY2025, 2.83% down from the prior year.
  • Gross Profit was $309.4 million for Q1 2026 at Bio-Rad Laboratories, down from $345.2 million in the prior quarter.
  • Over five years, Gross Profit peaked at $402.6 million in Q1 2022 and troughed at $306.0 million in Q1 2025.
  • The 5-year median for Gross Profit is $355.1 million (2024), against an average of $354.3 million.
  • Year-over-year, Gross Profit fell 14.64% in 2022 and then increased 6.02% in 2024.
  • A 5-year view of Gross Profit shows it stood at $397.1 million in 2022, then decreased by 7.76% to $366.3 million in 2023, then dropped by 6.63% to $342.0 million in 2024, then increased by 0.94% to $345.2 million in 2025, then dropped by 10.37% to $309.4 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Gross Profit are $309.4 million (Q1 2026), $345.2 million (Q4 2025), and $343.4 million (Q3 2025).